EGFR and neoplasm: Thus, we systematically assessed the mRNA expression levels of 28 cytokine encoding genes in TCGA tumor samples of 500 LUAD patients according to diverse clinicopathological factors (age, gender and tumor stage) and common driver mutations (EGFR and KRAS) and thereby determined their prognostic values with respect to overall survival and time to recurrence.